Rosetta Genomics Ltd.
Rosetta Genomics Ltd. (ROSGQ) Stock Overview
Explore Rosetta Genomics Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
593
P/E Ratio
-0.00
EPS (TTM)
$-0.27
ROE
-1.35%
ROSGQ Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Rosetta Genomics Ltd. (ROSGQ) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 593. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.